181

Last update : 09/05/2017

- Student health survey in 2005

Head : Fontaine Danièle
Dion Nicolas

Main objective

To study student health problems with a focus on mental health issues; to identify the relationship between socio-demographic characteristics and student perceptions of health and behaviour; student perception and use of health care system; to identify prevention requests in order to refine and develop regional student health-insurance plans and programmes.

Inclusion criteria

Students associated with six regional student health-insurance companies: Mutuelle Étudiants de Provence (MEP), Mutuelle Générale des Étudiants de l'Est (MGEL), Société Mutualiste des Étudiants de Bretagne-Atlantique (SMEBA), Société Mutualiste des Étudiants du Nord-Ouest (SMENO) Société Mutualiste des Étudiants de la Région Parisienne (SMEREP), VITTAVI

Last update : 09/05/2017

- Case-Control Study on Patients with Addictive Behaviour

Head : Falissard Bruno, Inserm U1018 – Centre for Research in Epidemiology and Population Health – Team: Gender, Sexual and Reproductive Health
Godart Nathalie

Version 1

182

Last update : 09/05/2017

- Case-Control Study on Patients with Addictive Behaviour

Head : Falissard Bruno, Inserm U1018 – Centre for Research in Epidemiology and Population Health – Team: Gender, Sexual and Reproductive Health
Godart Nathalie

Main objective

To verify whether anxiety disorders are more common in women with eating disorders.

Inclusion criteria

Patients with eating disorders (multicentric random draw).

Last update : 09/05/2017

B030 - Observational study: Conditions of use of duloxetine in France

Head : Laboratoire , Eli Lilly France

Version 1

183

Last update : 01/01/2020

B030 - Observational study: Conditions of use of duloxetine in France

Head : Laboratoire , Eli Lilly France

Main objective

Primary objective: evaluate the conditions for use of duloxetine in routine practice;
Secondary objectives: characteristics of the patients treated by duloxetine, profiles of duloxetine prescribers, characteristics of treatment.

Inclusion criteria

Patient receiving duloxetine in a pharmacy regardless of the indication, whether treatment initiation or renewal

Last update : 01/01/2020

CADASIL - CADASIL patient cohort

Head : Chabriat Hugues, CERVCO CENTRE DE RÉFÉRENCES POUR LES MALADIES RARES DES VAISSEAUX DU CERVEAU ET DE L'OEIL, HOPITAL LARIBOISIERE

Version 2

184

Last update : 12/01/2017

CADASIL - CADASIL patient cohort

Head : Chabriat Hugues, CERVCO CENTRE DE RÉFÉRENCES POUR LES MALADIES RARES DES VAISSEAUX DU CERVEAU ET DE L'OEIL, HOPITAL LARIBOISIERE

Main objective

General objective: prospective study of patients with Notch 3 gene mutation thought to cause CADASIL: research into prognostic factors and useful markers for preventative treatment trial. Secondary objectives: - To determine clinical-radiological correlations - Modifying factors of clinical phenotype and MRI studies - Prognostic and progressive factors - Clinical phenotype variability - Natural history of disease

Inclusion criteria

Adult patients with Notch 3 genetic mutation thought to cause CADASIL

Last update : 12/01/2017

DAIFI: Outcome Following Initiation of In Vitro Fertilisation (Devenir Après Initiation d'un traitement par Fécondation In vitro) - Cohort of Couples Starting In Vitro Fertilisation

Head : de La Rochebrochard Elise, Ined – Inserm – University of Paris-Sud 11 (Ined UR14/Inserm CESP 1018)

Version 1

185

Last update : 01/01/2020

DAIFI: Outcome Following Initiation of In Vitro Fertilisation (Devenir Après Initiation d'un traitement par Fécondation In vitro) - Cohort of Couples Starting In Vitro Fertilisation

Head : de La Rochebrochard Elise, Ined – Inserm – University of Paris-Sud 11 (Ined UR14/Inserm CESP 1018)

Main objective

General aim: To assess the likelihood of long-term parental project fulfilment among a population of couples beginning IVF treatment.
Secondary aim: To assess the cumulative IVF success rate, treatment discontinuation and spontaneous births after stopping IVF treatment.

Inclusion criteria

— female
— adult
— started IVF treatment between 2000 and 2002 in one of the IVF centres participating in the study.

Last update : 01/01/2020

OCSIGEN - Follow-up cohort of asthmatic patient treated with inhaled corticosteroid

Head : Pribil Céline, Laboratoire GSK

Version 2

186

Last update : 01/01/2019

OCSIGEN - Follow-up cohort of asthmatic patient treated with inhaled corticosteroid

Head : Pribil Céline, Laboratoire GSK

Main objective

Describe the conditions of use of the fluticasone and other inhaled corticosteroids in a pragmatic situation in general practice and in specialized pneumology, evaluate the severity of the asthma of patients cared for and measure the adequacy of the care with the national recommendations

Inclusion criteria

GP section:
The eligible population is defined by all of the asthmatic patients over the age of 15 years who have consulted at least twice in the previous year and in whom an inhaled corticotherapy is in progress (at least one prescription in the last six months). Patients defined as such who come to consult spontaneously for asthma during the period of inclusion will also be included. Refusal to participate and the association of the asthma with an OCPD are criteria for non-inclusion.

Pneumologist section:
Asthmatic persons cared for in liberal pneumology present in the practice of the investigators of the study and meeting the inclusion criteria

Last update : 01/01/2019